Cancer Therapy Market Analysis and Forecast 2017-2021

There are many types of cancer therapies based on the type and development stage of cancer. Chemotherapy is a type of cancer treatment that uses drugs to kill cancer cells. It is used to treat many types of cancer, however can cause damage to many growing cells, including some healthy cells. Hormone therapy or endocrine therapy is a treatment that slows or stops the growth of breast and prostate cancers that use hormones to grow. Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Radiation therapy is a type of cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. Stem cell transplants are procedures that restore blood-forming stem cells in cancer patients who have had theirs destroyed by very high doses of chemotherapy or radiation therapy. Targeted therapy is a type of cancer treatment that targets the changes in cancer cells that help them grow, divide, and spread.

Browse Cancer Therapy Market by Therapy Type (Chemotherapy, Hormonal Therapy, Immunotherapy, Radiation Therapy, Stem Cell Transplant, Targeted Therapy, Others), Disease Type (Breast Cancer, Hematological Malignancy, Prostate Cancer, Pulmonary Cancer, Skin Cancer, Others) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/cancer-therapy-market/

The global cancer therapy market segmentation is based on therapy type (chemotherapy, hormonal therapy, immunotherapy, radiation therapy, stem cell transplant, targeted therapy, others), and disease type (breast cancer, hematological malignancy, prostate cancer, pulmonary cancer, skin cancer, others).

The global cancer therapy market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global cancer therapy market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World. The global cancer therapy market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.

Major players operating in the global cancer therapy market and profiled in this report include Amgen, Inc., Celgene Corporation, GlaxoSmithKline PLC, Johnson and Johnson, Merck & Co., Inc., Novartis, Pfizer, Inc., and Roche Holdings.

1. Therapy Type
1.1. Chemotherapy
1.2. Hormonal Therapy
1.3. Immunotherapy
1.4. Radiation Therapy
1.5. Stem Cell Transplant
1.6. Targeted Therapy
1.7. Others

2. Disease Type
2.1. Breast Cancer
2.2. Hematological Malignancy
2.3. Prostate Cancer
2.4. Pulmonary Cancer
2.5. Skin Cancer
2.6. Others

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.3. Latin America (Brazil, Mexico, Rest of LA)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World (Middle East & Africa)

4. Company Profiles
4.1. Amgen, Inc.
4.2. Celgene Corporation
4.3. GlaxoSmithKline PLC
4.4. Johnson and Johnson
4.5. Merck & Co., Inc.
4.6. Novartis
4.7. Pfizer, Inc.
4.8. Roche Holdings

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/cancer-therapy-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.